Screening and prostate-cancer mortality in a randomized European study.

Slični predmeti

• Prostate-cancer mortality at 11 years of follow-up.
  od: Schröder, F, i dr.
  Izdano: (2012)
• Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
  od: Roobol, M, i dr.
  Izdano: (2009)
• Test sensitivity in the European prostate cancer screening trial: results from Finland, Sweden, and the Netherlands.
  od: Auvinen, A, i dr.
  Izdano: (2009)
• On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
  od: Bangma, C, i dr.
  Izdano: (2010)
• Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
  od: de Koning, H, i dr.
  Izdano: (2002)